BÁO CÁO Y HỌC: " A HIGH SERUM LEVEL OF EOTAXIN (CCL 11) IS ASSOCIATED WITH LESS RADIOGRAPHIC PROGRESSION IN EARLY RHEUMATOID ARTHRITIS PATIENTS" DOC

past decade. Where on one hand, this treatment has proven its effectiveness in ideal population; it has also identified some special populations by way of poor response or difficulties faced due to co morbid conditions. These special populations include patients with cirrhosis, non responders to pri[r]

24, the likelihood of an SVR is virtually nil and treatment can be stopped or continued with the only aim to slow liver disease progression in patients with a severe prognosis, without any hope to eradicate infection (Figure 1A) [18, 22]. Ongoing trials are studying whether a pr[r]

Cirrhosis), is a multicenter study of the potential benefit of prolonged peginterferon therapy in mitigating the progression of fibrotic liver disease. [8] In this study, 391 of the 1045 patients enrolled into the initial “lead-in” phase had biopsy proven cirrhosis. Preliminary results show t[r]

3. Department of Medical Technology, Nagoya University School of Health Sciences, 1-1-20 Daikominami, Higashi-ku, Na-goya, 461-8673 Japan Correspondence to: Simon Itou, Department of Preventive Medicine / Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, 65 Ts[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in pa[r]

association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in pa[r]

Cirrhosis), is a multicenter study of the potential benefit of prolonged peginterferon therapy in mitigating the progression of fibrotic liver disease. [8] In this study, 391 of the 1045 patients enrolled into the initial “lead-in” phase had biopsy proven cirrhosis. Preliminary results show t[r]

acceptable participation rate as well as less selection bias. We have chosen to report from the youngest age cohort participating in “The Prospective Population Study of Women in Gothenburg” as this was the age group in which lung function status was most thoroughly examined and selection bias due t[r]

Int. J. Med. Sci. 2006, 3 63International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):63-68 ©2006 Ivyspring International Publisher. All rights reserved Review A Practical Approach to Managing Patients with HCV Infection Richard H. Huang, and Ke-Qin Hu Division of Gast[r]

which is the final irreversible stage characterized by parenchymal nodules with encircling fibrous septa. The hepatitis C virus is not considered to directly injure the liver but it rather triggers an HCV-specific lymphoproliferation. Through profuse cytokine production and also a direct cyto[r]

glycemic control. Strength training is the most effective lifestyle intervention to increase muscle mass but limited data is available in older adults with diabetes. We determined the influence of strength training on muscle quality (strength per unit of muscle mass), skeletal muscle fiber hypertrop[r]

relatively similar pattern to that found in the untreated control cells. The pairwise comparison analysis demonstrated four significantly up-regulated (COBRA1, ITGB4, STAU2, and HMGN3) genes and one down-regulated (ANK3) gene. All these genes exert their function on transcriptional and translational[r]

University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 Japan. Tel: +81-52-744-2133, Fax: +81-52-744-2971, e-mail: y-goto@med.nagoya-u.ac.jp Received: 2006.09.22; Accepted: 2006.10.25; Published: 2006.11.01 Background: Various single nucleotide polymorphisms (SNPs) have ex[r]

Trepo C, et al. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. J Clin Virol 2005;33:150-157. 49. Villa E, Grottola A, Buttafoco P, Colantoni A, Bagni A, Ferretti I, Cremonini C, et al. High doses of alpha-interferon are required in[r]

highly significant association between the rare C allele and lower plasma HDL concentrations in female subjects. The effect remained significant after correcting for multiparametric testing according to Bonferoni and was seen only in subjects with a BMI below the median. In addition, the non-[r]

Int. J. Med. Sci. 2006, 3 117International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(4):117-123 ©2006 Ivyspring International Publisher. All rights reserved Review PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Jos[r]

Int. J. Med. Sci. 2007, 4 83International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2007 4(2):83-93 © Ivyspring International Publisher. All rights reserved Review Rasburicase represents a new tool for hyperuricemia in tumor lysis syn-drome and in gout Lisa Cammalleri and Mar[r]

1a, 1b, 2a...).[4] Frequent HCV mutations and numerous subtypes have made the search for an HCV vaccine challenging. There is strong evidence demonstrating the association of chronic HCV infection to cirrhosis and hepatocellular carcinoma (HCC). HCV is a mounting global health c[r]

but Cys-C of ≥1.0mg/L; Group III (abnormal), serum Cr of ≥1.3mg/dL. All patients belonging to Group III showed serum levels of Cys-C of 1.0mg/mL or more. Each bar represents the mean ± SD. *P<0.05, significantly different from Group I. 4. Discussion Digoxin shows a narrow therapeutic[r]

tion. Exercise is a known stress condition that con-sumes muscle glycogen rapidly. During the recovery period following exercise, the whole-body glucose tolerance and the rate of muscle glycogen storage in-creases simultaneously, resulting in glycogen super-compensation [5]. This normal adapt[r]